Browsing: Patients
The Society of Nuclear Medicine and Molecular Imaging (SNMMI) and the European Association of Nuclear Medicine (EANM) have issued a…
Screening for liver cancer among patients with cirrhosis nearly doubled when they were sent a signed order from their specialist,…
The PrE0405 phase 2 trial met its primary endpoint, achieving a complete response (CR) rate of 85% in 33 patients…
The combination of the JAK inhibitor ruxolitinib with the BCL-xL inhibitor navitoclax was twice as effective in reducing spleen enlargement…
Patients with low-risk ductal carcinoma in situ (DCIS) who omitted adjuvant radiotherapy after breast-conserving surgery had comparable five-year outcomes to…
PlaqueTec, a company identifying endotype-specific biomarkers to advance precision medicine for coronary artery disease (CAD), announced today that it has…